These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 6097273
1. Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension. Felder K, Witte PU. Arzneimittelforschung; 1984; 34(10B):1452-4. PubMed ID: 6097273 [Abstract] [Full Text] [Related]
2. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). Schölkens BA, Becker RH, Kaiser J. Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268 [Abstract] [Full Text] [Related]
3. Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers. Witte PU, Metzger H, Eckert HG, Irmisch R. Arzneimittelforschung; 1984; 34(10B):1448-51. PubMed ID: 6097272 [Abstract] [Full Text] [Related]
4. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. Unger T, Fleck T, Ganten D, Lang RE, Rettig F. Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269 [Abstract] [Full Text] [Related]
5. Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). Teetz V, Geiger R, Henning R, Urbach H. Arzneimittelforschung; 1984; 34(10B):1399-401. PubMed ID: 6097264 [Abstract] [Full Text] [Related]
6. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension. Lenz T, Distler A, Haller H, Meyer-Sabellek W, Wilp C, Tansey MJ, Eckert HG, Metzger H, Irmisch R, Philipp T. Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438 [Abstract] [Full Text] [Related]